Literature DB >> 26089053

Overall and progression-free survival of stage 4 cutaneous squamous cell carcinoma at a single large referral center.

Gefei Alex Zhu1, Anne Lynn Su Chang2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26089053     DOI: 10.1016/j.jaad.2015.03.028

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Metastatic Cutaneous Squamous Cell Carcinoma in Liver Successfully Treated With Partial Hepatectomy and Adjuvant Irinotecan Chemotherapy.

Authors:  Yasuhiko Asahina; Yoshio Nakamura; Keiji Tanese; Ikuko Hirai; Keitaro Fukuda; Masayuki Amagai; Takeru Funakoshi
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

2.  Association of VEGF Gene Polymorphisms with the Risk and Prognosis of Cutaneous Squamous Cell Carcinoma.

Authors:  Xiao-Juan Nie; Wen-Min Liu; Li Zhang
Journal:  Med Sci Monit       Date:  2016-10-12

3.  Recent Advanced in the Treatment of Advanced SCC Tumors.

Authors:  Nicole Basset-Seguin; Eve Maubec
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

4.  Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.

Authors:  Mary B Kelley; Taylor J Geddes; Maria Ochiai; Noah M Lampl; W Wade Kothmann; Sara R Fierstein; Victoria Kent; Kathleen DeCicco-Skinner
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

5.  Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).

Authors:  Maki Ishii; Ikuko Hirai; Keiji Tanese; Takayuki Fusumae; Yoshio Nakamura; Keitaro Fukuda; Hiroshi Uchi; Kenji Kabashima; Atsushi Otsuka; Kenji Yokota; Naoya Yamazaki; Kenjiro Namikawa; Taku Fujimura; Tatsuya Takenouchi; Yuki Yamamoto; Mana Nishiguchi; Yasunori Sato; Masayuki Amagai; Takeru Funakoshi
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.